IPO registrations (S-1, F-1) · Registrants
DEXCOM INC
- SEC CIK
- 1093557 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2005-02-01, last 2006-04-26; 2 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2005-04-14; declared effective 2007-08-28
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 6340 SEQUENCE DRIVE, San Diego, CA 92121
- EIN
- 33-0857544
- Ticker
- DXCM (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- DEXCOM INC on the corporate pages
Offering terms
- Final price
- $12.00 per share (424B4 filed 2005-04-14, an initial public offering)
- Shares sold
- 4,700,000
- Gross proceeds
- $56,400,000 before underwriting discounts and any over-allotment option
- Lead underwriters
- Piper Sandler
- Syndicate
- Cowen; William Blair; First Albany Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: DEXCOM. INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: DexCom, Inc. Fuzzy (name and state)
- Business registration: DexCom, Inc. Fuzzy (name and state)
- Business registration: DEXCOM Inc. Fuzzy (name and state)
- Business registration: DEXCOM, INC. Fuzzy (name and state)
- Business registration: DEXCOM, INC. Fuzzy (name and state)
- Business registration: DEXCOM, INC. Fuzzy (name and state)
- Business registration: DEXCOM, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: DEXCOM INC EXACT (EIN (EXACT))
- Political committee (FEC): DEXCOM, INC. POLITICAL ACTION COMMITTEE (DEXCOM PAC) (connected to DEXCOM, INC.) Fuzzy (name and state)
- Federal award recipient: DEXCOM, INC. Fuzzy (name and state)
- Form D issuer: DEXCOM INC EXACT (CIK (EXACT))
- Lobbying client: DEXCOM Fuzzy (name and state)
- Lobbying client: DEXCOM Fuzzy (name and state)
- Lobbying client: DEXCOM, INC. Fuzzy (name and state)
- Lobbying client: DEXCOM, INC. Fuzzy (name and state)
- Lobbying client: DEXCOM, INC. Fuzzy (name and state)
- Lobbying client: DEXCOM, INC. Fuzzy (name and state)
- Lobbying client: DEXCOM, INC. Fuzzy (name and state)
- Lobbying client: DEXCOM, INC. Fuzzy (name and state)
- Lobbying registrant: DEXCOM, INC. Fuzzy (name and state)
- SEC filer: DEXCOM INC EXACT (CIK (EXACT))
- Person page: Teri L Lawver Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-02-01 | S-1 | S-1 (registration) | DEXCOM INC | 0001047469-05-002052 ↗ |
| 2005-02-15 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-003922 ↗ |
| 2005-03-03 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-005246 ↗ |
| 2005-03-15 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-006437 ↗ |
| 2005-03-24 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-007514 ↗ |
| 2005-03-25 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-007840 ↗ |
| 2005-03-28 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-007912 ↗ |
| 2005-04-05 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-05-009239 ↗ |
| 2005-04-14 | 424B4 | 424B4 (final prospectus) | DEXCOM INC | 0001047469-05-010113 ↗ |
| 2006-04-06 | S-1 | S-1 (registration) | DEXCOM INC | 0001047469-06-004604 ↗ |
| 2006-04-11 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-06-004926 ↗ |
| 2006-04-21 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-06-005444 ↗ |
| 2006-04-26 | S-1/A | S-1/A (amendment) | DEXCOM INC | 0001047469-06-005697 ↗ |
| 2006-04-27 | S-1MEF | S-1MEF (added securities) | DEXCOM INC | 0001047469-06-005775 ↗ |
| 2006-04-27 | 424B4 | 424B4 (final prospectus) | DEXCOM INC | 0001047469-06-005780 ↗ |
| 2007-08-28 | EFFECT | EFFECT (declared effective) | DEXCOM INC | 9999999995-07-003445 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-04-05 | S-1/A | registration statement | $2.69 | 6,395,423 | $17,203,687 | 0 | primary document; price line, shares headline, proceeds computed | document ↗ | ||
| 2005-04-14 | 424B4 | final prospectus | $12.00 | 4,700,000 | $56,400,000 | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| SKYLER JAY S | Director | 51 | 2006–2023 | ||
| CARNEY SEAN | Director | 16 | 2006–2008 | ||
| GREGG TERRANCE H | Director; Director,Officer; Director,Officer,TenPercentOwner; Officer | CEO; Executive Chairman; Former Executive Chairman; President and CEO; President & CEO | 158 | 2006–2018 | |
| Lucas Donald A | Director | 25 | 2006–2010 | ||
| LUCAS DONALD L | Director | 16 | 2006–2010 | ||
| Kemper Steven J | Officer | Chief Financial Officer | 4 | 2006–2007 | |
| Brauker James H | Officer | VP Research & Development; VP, Research & Development | 5 | 2006–2008 | |
| NELSON GLEN D | Director | 5 | 2006–2008 | ||
| BLICKENSTAFF KIM D | Director | 7 | 2006–2007 | ||
| ANDREWS TAE | Officer | Vice President of Marketing | 4 | 2006–2007 | |
| Ahrens Brenton Karl | Director | 1 | 2006 | ||
| Pacelli Steven Robert | Officer | CAO; COO; EVP Managing Director Dexcom V; EVP Strategy and Corporate Dev; EVP, Strategy & Corp. Dev.; Managing Dir., Dexcom Ventures; SVP, Corporate Affairs; Vice President Legal Affairs; Vice President, Legal Affairs | 166 | 2006–2023 | |
| Split Rock Partners LLC | TenPercentOwner | 1 | 2006 | ||
| ST PAUL FIRE & MARINE INSURANCE CO | TenPercentOwner | 1 | 2006 | ||
| ST PAUL TRAVELERS COMPANIES INC | TenPercentOwner | 1 | 2006 | ||
| WARBURG PINCUS & CO | TenPercentOwner | 1 | 2006 | ||
| WARBURG PINCUS LLC | TenPercentOwner | 1 | 2006 | ||
| Warburg Pincus Partners LLC | TenPercentOwner | 1 | 2006 | ||
| WARBURG PINCUS PRIVATE EQUITY VIII L P | TenPercentOwner | 1 | 2006 | ||
| Balo Andrew K | Officer; OfficerOther | *; EVP, Clinical and Regulatory; EVP, Clinical, Regulatory; EVP, Clinical, Regulatory &; EVP, Global Medical Affairs; EVP, Reg. Strategy, Clinical; EVP Regulatory Strategy Clinic; SVP, Regulatory and Clinical; VP, Clinical & Regulatory; VP of Clinical & Regulatory | 127 | 2006–2023 | |
| Brister Mark | Officer | VP, Advanced Development Team; VP Advanced Development Teams; VP, Advanced Development Teams | 3 | 2006–2007 | |
| Rasdal Andrew P | Officer | President & CEO | 1 | 2006 | |
| VALDES JORGE A | Officer | CTO; Former CTO; SVP of Operations; Vice President of Engineering | 72 | 2006–2017 | |
| KELLOGG RODNEY L | Officer | Vice President of Sales | 3 | 2006–2008 | |
| Riolo John | Officer | VP of Quality Assurance | 2 | 2007 | |
| ROPER JESS | Officer | Former SVP, CFO; Interim CFO; SVP, CFO; VP, CFO | 65 | 2007–2017 | |
| SAYER KEVIN R | Director; Director,Officer | Chairman, CEO & President; Executive Chair; President; President & CEO; President CEO and Chairman; President, CEO and Chairman; President CEO and Chairman of; President, CEO & Chairman; President & COO | 121 | 2007–2026 | |
| LORD JONATHAN T MD | Director | 20 | 2008–2016 | ||
| GRAHAM CLAUDIA | Officer | VP Marketing; VP, Marketing | 6 | 2008–2010 | |
| GERHARDSSON PETER | Officer | VP, Int'l Bus. Dev.; VP, Int'l Business Development | 3 | 2008–2010 | |
| JOHNSON LAURA | Officer | V.P., Intellectual Property | 4 | 2008–2010 | |
| MOY JEFFREY | Officer | EVP Operations; SVP Operations; SVP, Operations; V.P., Manufacturing; V. P., Operations | 79 | 2008–2020 | |
| YANG RICHARD | Officer | V.P., Strategic Affairs | 4 | 2008–2010 | |
| LISTER JOHN | Officer | General Counsel, VP of HR; General Manager, EMEA; Sr. VP, General Counsel; VP, Legal Affairs; VP of Legal Affairs | 56 | 2009–2017 | |
| DOUBLEDAY RICHARD | Officer | EVP Chief Commercial Officer; EVP, Chief Commercial Officer; Sr. VP. Worldwide Sales; SVP, Worldwide Sales; VP of Sales | 119 | 2009–2021 | |
| TOPOL ERIC | Director | 25 | 2009–2025 | ||
| AUGUSTINOS NICHOLAS | Director | 41 | 2009–2026 | ||
| CARNER DAVID | Officer | VP, Quality Assurance | 2 | 2010 | |
| DOORDAN MARTIN | Director | 6 | 2011–2012 | ||
| KAHN BARBARA | Director | 30 | 2011–2024 | ||
| ALTMAN STEVEN R | Director | 40 | 2013–2026 | ||
| FOLETTA MARK G | Director | 41 | 2014–2026 | ||
| Abbey Donald | Officer | EVP Global Business Services I; EVP Quality; EVP Quality and Regulatory Aff; EVP Quality Regulatory Affairs; EVP, Quality & Regulatory Afrs | 25 | 2016–2023 | |
| Murphy Patrick Michael | Officer | *; EVP, Chief Legal Officer; SVP, GC & Chief Compliance Off; SVP Legal Affairs; SVP, Legal Affairs; VP, Legal Aff & Chf Compl Ofcr | 43 | 2016–2021 | |
| Leach Jacob Steven | Director,Officer; Officer | Chief Operating Officer; Chief Technology Officer; EVP Chief Operating Officer; EVP, Chief Operating Officer; EVP Chief Technology Officer; President, CEO, and Director; President & COO; SVP, Research & Development | 47 | 2017–2026 | |
| ACE HEATHER S | Officer | SVP Human Resources | 13 | 2017–2020 | |
| Collins Richard Alexander | Director | 19 | 2017–2026 | ||
| Sun Kevin M | Officer | Interim CFO; VP, Corp Controller & Treasury | 2 | 2017–2018 | |
| Blackford Quentin S. | Officer | Chief Operating Officer; Chief Operating Officer & CFO; EVP, CFO, PFO & PAO; EVP Chief Financial Officer | 17 | 2017–2021 | |
| Heller Bridgette P | Director | 19 | 2019–2026 | ||
| Selvaraj Shelly Ramasamy | Officer | SVP Chief Information Officer; SVP Information Technology | 23 | 2020–2023 | |
| Sylvain Jereme M | Officer | EVP, Chief Financal Officer; EVP Chief Financial Officer; EVP, Chief Financial Officer; SVP, Finance & CAO | 43 | 2020–2026 | |
| Dahut Karen M | Director | 9 | 2020–2025 | ||
| Stern Sadie | Officer | Chief Human Resources Officer; EVP Chief HR Officer; EVP, Chief HR Officer; EVP Chief Human Resources; EVP Chief Human Resources Off; EVP Chief Human Resources Offi; EVP Chief People & Culture Off | 41 | 2020–2026 | |
| Malady Kyle | Director | 9 | 2020–2026 | ||
| Regan Barry J. | Officer | EVP Global Operations; EVP Operations | 17 | 2020–2023 | |
| Flynn Paul R | Officer | EVP Global Revenue; EVP, Global Revenue | 10 | 2021–2023 | |
| Patterson Chad | Officer | EVP Global Marketing; EVP, Global Marketing | 10 | 2021–2022 | |
| Shrishrimal Sumi | Officer | SVP Chief Risk Officer | 6 | 2021–2022 | |
| Brown Michael Jon | Officer | EVP Chief Legal Compliance Off; EVP Chief Legal Officer; EVP, Chief Legal Officer | 31 | 2022–2026 | |
| Dolan Matthew Vincent | Officer | *; EVP Strategy and Corporate; EVP Strategy and Corporate Dev; EVP Strategy & Corp Dev; EVP, Strategy & Corporate Dev; SVP Corporate Development; SVP Corporate Strategy-Develop | 15 | 2022–2025 | |
| Naganathan Girish | Officer | EVP Chief Technology Officer | 4 | 2022–2023 | |
| Lawver Teri L | Officer | EVP Chief Commercial Officer | 4 | 2023–2024 | person page Fuzzy |
| Driscoll Rimma | Director | 5 | 2023–2026 | ||
| GALA RENEE D | Director | 5 | 2025–2026 | ||
| Coleman Jon | Officer | EVP, Chief Commercial Officer | 5 | 2025–2026 | |
| Ashley Euan A. | Director | 3 | 2025–2026 | ||
| Osterloh Albert Frederick IV | Director | 3 | 2026 | ||
| Boehnlein Glenn S | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-05-18 | DEXCOM INC | Biotechnology | $7,225,664 | $7,225,664 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | DEXCOM. INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | DEXCOM INC | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | DEXCOM INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | DexCom, Inc. | State business registries | name and state | |
| Business registration | DexCom, Inc. | State business registries | name and state | |
| Business registration | DEXCOM Inc. | State business registries | name and state | |
| Business registration | DEXCOM, INC. | State business registries | name and state | |
| Business registration | DEXCOM, INC. | State business registries | name and state | |
| Business registration | DEXCOM, INC. | State business registries | name and state | |
| Business registration | DEXCOM, INC. | State business registries | name and state | |
| Form 5500 plan sponsor | DEXCOM INC | EIN (EXACT) | ||
| Political committee | DEXCOM, INC. POLITICAL ACTION COMMITTEE (DEXCOM PAC) (connected to DEXCOM, INC.) | Campaign finance (FEC) | name and state | |
| Federal award recipient | DEXCOM, INC. | Federal spending (USAspending) | name and state | |
| Lobbying client | DEXCOM | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying registrant | DEXCOM, INC. | Federal lobbying (LDA) | name and state | |
| Person page | Teri L Lawver | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CA first:
- FUSION MEDICAL TECHNOLOGIES INC CA
- ENDOLOGIX INC /DE/ CA
- CEMAX ICON INC CA
- TRYLON CORP CA
- R2 TECHNOLOGY INC CA
- CERUS CORP CA
- SOMNUS MEDICAL TECHNOLOGIES INC CA
- MICRUS ENDOVASCULAR CORP CA
- AEROGEN INC CA
- IOMED LLC CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology